Results 181 to 190 of about 25,145 (199)

Exploding Implantable Cardioverter Defibrillator

Journal of Cardiovascular Electrophysiology, 2001
Exploding Implantable Cardioverter Defibrillator. A 79‐year‐old man with a pectoral implantable cardioverter defibrillator (ICD) system underwent periodic defibrillation threshold testing 18 months after implant. Attempted delivery of a 15‐J shock caused a light flash above the pocket and a loud “pop.” High‐voltage lead impedance was < 20 Ω. Pocket
openaire   +2 more sources

Implantable Cardioverter Defibrillator Therapy

The Journal of Cardiovascular Nursing, 2005
Sudden cardiac death (SCD) is a major healthcare problem worldwide. The majority of SCD events occur in patients with clinically recognized heart disease and most episodes result from ventricular tachyarrhythmias. Implantable cardioverter defibrillator (ICD) therapy prevents SCD in specific patient populations.
openaire   +2 more sources

Subcutaneous Implantable Cardioverter-Defibrillator Technology

Cardiac Electrophysiology Clinics, 2009
The advent of subcutaneous implantable cardioverter-defibrillator (ICD) systems represents a paradigm shift for the detection and therapy of ventricular tachyarrhythmias. Despite advances in transvenous lead technology, problems remain that notably include requirement for technical expertise; periprocedural complications during implantation and ...
Anurag, Gupta, Amin, Al-Ahmad, Paul J, Wang   +2 more
openaire   +3 more sources

Implantable cardioverter-defibrillators

Current Opinion in Cardiology, 1991
Implantable cardioverter-defibrillators (ICD) have advanced from a hypothetical device (1970s), to the first human trials (1980s), to the current and future models capable of differentiating ventricular tachyarrhythmias and bradyarrhythmias and of applying selective electrical therapy.
G P, Fazio, E P, Veltri
openaire   +2 more sources

Implantable Cardioverter‐Defibrillators in Children

Pacing and Clinical Electrophysiology, 2008
Implantable cardioverter‐defibrillators (ICD) in adults have shown to be safe and effective for both primary and secondary prevention of sudden cardiac death (SCD). In children and patients with congenital heart disease prospective trials to evaluate the safety and efficacy of these devices are still lacking.
openaire   +2 more sources

Implantable cardioverter defibrillator implantation

2018
This chapter covers implantable cardioverter defibrillators (ICD) implantation. Pre-procedure considerations such as the operative conditions, counselling, and consent are covered. Patient preparation and the necessary equipment and staff are defined. The implantation procedure is discussed in detail.
Rajesh Chelliah, Raj Khiani
openaire   +1 more source

Implantable cardioverter defibrillator

Abstract This chapter focuses on implantable cardioverter defibrillator. Content is mapped to the ESC Core Curriculum and is ideal for candidates preparing to take the European Exam in Core Cardiology (EECC). To ensure effective revision, material is presented in short sections with bullet lists, tables, and boxes to highlight key facts.
Richard Bond, Howell Williams
openaire   +1 more source

Implantable Cardioverter-Defibrillators

1992
Sudden cardiac death due to malignant ventricular arrhythmias is one of the nation’s leading public health problems. An individual suffering such an event has only a 25% chance of survival [1]. Furthermore, patients suffering such an episode are at high risk for recurrent cardiac arrest.
openaire   +1 more source

Implantable Cardioverter-Defibrillators

2013
An implantable cardioverter defibrillator (ICD) is an active implantable medical device primarily used to deliver a high-energy electric shock to the heart via intracardial leads. The electric shock causes concurrent depolarization of all cell membranes in myocardial volume followed by an absolute refractory period.
openaire   +1 more source

[Implantable cardioverter defibrillator].

Nihon rinsho. Japanese journal of clinical medicine, 1996
ICD therapy has been believed to be a last resort therapy for preventing of sudden death due to VT/VF. Since 1980, when clinical use first began, ICD therapy has rapidly increased in use in Europe and in the United State. In Japan, in 1990 clinical investigation began, and in 1996 it received insurance reimbursement.
openaire   +3 more sources